Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management
Public ClinicalTrials.gov record NCT04443608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 4 Study of the Efficacy & Safety of Patiromer for Oral Suspension in Combination With Standard of Care Treatment in ED Patients With Hyperkalemia
Study identification
- NCT ID
- NCT04443608
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Comprehensive Research Associates
- Industry
- Enrollment
- 115 participants
Conditions and interventions
Conditions
Interventions
- Patiromer Powder for Oral Suspension [Veltassa] Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 7, 2020
- Primary completion
- Mar 8, 2023
- Completion
- Jun 2, 2023
- Last update posted
- Aug 30, 2023
2020 – 2023
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University School of Medicine | Stanford | California | 94305 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| Christiana Care | Newark | Delaware | 19718 | — |
| George Washington University | Washington D.C. | District of Columbia | 20037 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Hennepin Healthcare Research Institute | Minneapolis | Minnesota | 55415 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Washington University of St Louis | St Louis | Missouri | 63110 | — |
| Mt Sinai. Icahn School of Medicine | New York | New York | 10029 | — |
| Maimonides Medical Center | New York | New York | 11219 | — |
| Stony Brook University Hospital | Stony Brook | New York | 11794 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| University of Cincinnati | Cincinnati | Ohio | 45219 | — |
| Ohio State University. Wexner Medical Center | Columbus | Ohio | 43210 | — |
| JPS Health Network | Fort Worth | Texas | 76104 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| UT Memorial Hermann Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04443608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04443608 live on ClinicalTrials.gov.